Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study. by Carlo Cattrini, Matteo Capaia, Francesco Boccardo, Paola Barboro

Get full text

Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty? by Rosario Barranco, Carlo Messina, Alessandro Bonsignore, Carlo Cattrini, Francesco Ventura

Get full text

To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone by Elisa Zanardi, Davide Soldato, Maria Maddalena Latocca, Carlo Cattrini, Francesco Boccardo

Get full text

Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer by Carlo Cattrini, Melissa Bersanelli, Maria Maddalena Latocca, Benedetta Conte, Giacomo Vallome, Francesco Boccardo

Get full text

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer by Carlo Cattrini, Elena Castro, Rebeca Lozano, Elisa Zanardi, Alessandra Rubagotti, Francesco Boccardo, David Olmos

Get full text

Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer by Carlo Cattrini, Paola Barboro, Alessandra Rubagotti, Linda Zinoli, Elisa Zanardi, Matteo Capaia, Francesco Boccardo

Get full text

Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review by Carlo Cattrini, Orazio Caffo, Ugo De Giorgi, Alessia Mennitto, Alessandra Gennari, David Olmos, Elena Castro

Get full text

Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer by Carlo Cattrini, Rodrigo España, Alessia Mennitto, Melissa Bersanelli, Elena Castro, David Olmos, David Lorente, Alessandra Gennari

Get full text

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism? by Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, Alessia Mennitto, Carlo Messina, Chiara Airoldi, Gianmarco Vannini, Melissa Bersanelli

Get full text

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastat... by Carlo Cattrini, Alessandra Rubagotti, Linda Zinoli, Luigi Cerbone, Elisa Zanardi, Matteo Capaia, Paola Barboro, Francesco Boccardo

Get full text

Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis by Carlo Cattrini, Carlo Messina, Chiara Airoldi, Sebastiano Buti, Giandomenico Roviello, Alessia Mennitto, Orazio Caffo, Alessandra Gennari, Melissa Bersanelli

Get full text

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer by Carlo Cattrini, Davide Soldato, Alessandra Rubagotti, Linda Zinoli, Elisa Zanardi, Paola Barboro, Carlo Messina, Elena Castro, David Olmos, Francesco Boccardo

Get full text

Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights by Federica Biello, Francesca Platini, Francesca D’Avanzo, Carlo Cattrini, Alessia Mennitto, Silvia Genestroni, Veronica Martini, Paolo Marzullo, Gianluca Aimaretti, Alessandra Gennari

Get full text

Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients by Carlo Cattrini, Marcello Manfredi, Paola Barboro, Marco Ghirimoldi, Alessia Mennitto, Veronica Martini, Alessio Battioni, Marco Le Van, Simone Gobbato, Carmen Branni, Rahma Ben Ayed, David James Pinato, Fabio Catalano, Elisa Zanardi, Francesco Boccardo, Alessandra Gennari

Get full text

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospect... by Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli, Ugo De Giorgi, Nicole Brighi, Giuseppe Fornarini, Sara Elena Rebuzzi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Matteo Santoni, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Matteo Brunelli, Sebastiano Buti

Get full text

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients by Sebastiano Buti, Alessandro Olivari, Cristina Masini, Davide Bimbatti, Donata Sartori, Paola Ermacora, Carlo Cattrini, Maria Giuseppa Vitale, Ernesto Rossi, Claudia Mucciarini, Mimma Rizzo, Michele Sisani, Matteo Santoni, Giandomenico Roviello, Veronica Mollica, Vincenza Conteduca, Francesco Grillone, Marika Cinausero, Giuseppe Prati, Francesco Atzori, Marco Stellato, Francesco Massari, Melissa Bersanelli

Get full text

Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score by Giulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, Francesca Trentini, Ugo De Giorgi, Nicole Brighi, Chiara Tommasi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Enrico Maria Silini, Pasquale Rescigno, Sara Elena Rebuzzi, Giuseppe Fornarini, Federico Quaini, Giulia Claire Giudice, Giuseppe Luigi Banna, Sebastiano Buti

Get full text